Thromboelastography to Study Burn Coagulopathy

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
Francesco Egro
Study ID
NCT06879509
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Burn
  • Coagulation, Blood

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Thromboelastography — DIAGNOSTIC_TEST
    All participants will receive this intervention. Thromboelastography (TEG) is a blood test that provides a detailed assessment of the clotting process, measuring how blood clots form, strengthen, and dissolve. It offers real-time insights into a patient's coagulation status, helping to identify clotting disorders and guide treatment decisions.

Study Details

This pilot study examines the use of thromboelastography (TEG), a specialized blood test, to evaluate clotting abnormalities in burn patients. The study aims to understand how burn injuries impact the body's ability to form and break down blood clots over time. Specifically, the investigators will research whether the percentage of total body surface area burned (%TBSA) is associated with changes in blood clotting, track the evolution of clotting patterns during the first four weeks following a burn injury, and explore whether these changes can predict recovery or complications. By providing new insights into clotting dynamics in burn patients, the study seeks to improve diagnostic methods, enhance monitoring strategies, and guide treatments to optimize patient care and outcomes.

Key Dates

Start date
Jun 30, 2025
Status verified
Mar 2025
Primary completion
Aug 31, 2025
Completion
Aug 31, 2025

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Burn Thromboelastography Group
    Overall study population (all participants are in the same group). See eligibility for further details.

Primary Outcome Measure

Thromboelastography [ Time Frame: Duration of hospital length of stay, up to 28 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Pittsburgh Medical CenterPittsburghPennsylvania15219
Francesco M Egro, MD
[email protected]
(404) 861-7944‬
Hilary Y Liu, BS
[email protected]
4846315188
Francesco M Egro, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Pittsburgh, PA

By research site
University of Pittsburgh Medical Center· Pittsburgh, PA

Related Studies